
Share
Zyphra's beta release of Zonos-v0.1 introduces two high-fidelity text-to-speech models capable of real-time voice cloning, offering unprecedented expressiveness and immediacy for AI-driven communication tools.
Zyphra, a leading AI research and development company, has announced the beta release of Zonos-v0.1, a suite of two expressive and real-time text-to-speech (TTS) models that feature high-fidelity voice cloning. This release includes both a 1.6B transformer model and a 1.6B hybrid model, both of which are available under the Apache 2.0 license.
The key technical advancements in Zonos-v0.1 include:
For developers and researchers working in the field of TTS and voice cloning, Zonos-v0.1 offers several advantages:
Zonos-v0.1 includes two main models:
The Zonos-v0.1 suite is designed to be flexible and adaptable:

Benchmarking results show that both models perform exceptionally well:
The training process for Zonos-v0.1 involved several key steps:
Zonos-v0.1 is available for free under the Apache 2.0 license. The models can be accessed through the Zyphra playground or downloaded directly from their repository. For commercial use, users are encouraged to review the licensing terms and conditions.
The beta release of Zonos-v0.1 marks a significant step forward in the field of text-to-speech and voice cloning. With its real-time performance, high-fidelity voice cloning, and open-source availability, this suite of models offers valuable tools for developers and researchers looking to enhance their applications with natural and
Tags
Original Sources
About the author
Kai built ML infrastructure at a Bay Area startup before developing an obsession with transformer architectures and inference optimisation that eventually pulled him out of product work entirely. A stint at a compute research lab sharpened his instinct for what actually matters in a model release versus what is marketing. He writes from the inside — from the perspective of someone who has debugged the systems he is describing at three in the morning. He is allergic to hype and instinctively drawn to the unglamorous plumbing questions that everyone else skips over.
More from The Engineer →This Week's Edition
4 April 2025
88 articles
Related Articles

OpenEvidence Targets Hospitals to Expand Its AI Chatbot for Doctors
Products & Applications · 3 min

OpenEvidence Launches Voice AI to Enhance Physician Workflow
Products & Applications · 3 min

Doximity Accelerates AI Investment in 2026, Targeting Multibillion-Dollar Market
Products & Applications · 3 min
Related Articles

OpenEvidence Targets Hospitals to Expand Its AI Chatbot for Doctors
Products & Applications · 3 min

OpenEvidence Launches Voice AI to Enhance Physician Workflow
Products & Applications · 3 min

Doximity Accelerates AI Investment in 2026, Targeting Multibillion-Dollar Market
Products & Applications · 3 min
More Stories